Ovidrel

Before you begin using a medication, be sure to inform your doctor of any medical conditions or Allergies you may have, any medications you are taking, whether you are pregnant or breast-feeding, and any other significant facts about your health. These factors may affect how you should use Ovidrel (Chorionic-gonadotropin-alfa).

Blood Clots: Ovidrel (Chorionic-gonadotropin-alfa) may increase the chance of blood clot formation, causing a reduction of blood flow to organs or the extremities.

If you have a history of clotting you may be at increased risk of experiencing blood clot-related problems such as Heart Attack, stroke, pulmonary Embolism (blood clot in the blood vessels of the lungs), or clots in the deep veins of your leg. Discuss with your doctor how Ovidrel (Chorionic-gonadotropin-alfa) may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Ovidrel (Chorionic-gonadotropin-alfa), and whether any special monitoring is needed.

If you experience symptoms such as sharp pain and swelling in the leg, difficulty breathing, chest pain, blurred vision or difficulty speaking, contact your doctor immediately.

Multiple births: Multiple births may occur with fertility medications. Talk to your doctor about the risks of multiple births before beginning treatment.

Ovarian enlargement: Some women using Ovidrel (Chorionic-gonadotropin-alfa) may experience ovarian enlargement associated with abdominal bloating or pain. In most cases these symptoms go away without treatment within 2 or 3 weeks. If you experience these symptoms contact your doctor.

Ovarian hyperstimulation syndrome (OHSS): Treatment with Ovidrel (Chorionic-gonadotropin-alfa) can cause a condition called ovarian hyperstimulation syndrome (OHSS). With OHSS, too many follicles grow and cause abdominal or pelvic discomfort, pain, nausea, vomiting, and weight gain. Some women may experience difficulty breathing and diarrhea. OHSS can progress rapidly and may become serious. If you experience any of these symptoms, seek immediate medical attention.

Pregnancy: The effect of choriogonadotropin alpha on an unborn baby is not known. To avoid the possibility of harm to the baby, choriogonadotropin alpha should not be used during pregnancy.

Breast-feeding: It is not known if choriogonadotropin alpha passes into breast milk. If you are a breast-feeding mother and are taking Ovidrel (Chorionic-gonadotropin-alfa), it may affect your baby. Talk to your doctor about whether you should continue breast-feeding.

Children: Ovidrel (Chorionic-gonadotropin-alfa) is intended for use by women of child-bearing age and therefore, the safety and effectiveness of Ovidrel (Chorionic-gonadotropin-alfa) have not been established for children.

Seniors: Ovidrel (Chorionic-gonadotropin-alfa) is intended for use by women of child-bearing age and therefore, the safety and effectiveness of Ovidrel (Chorionic-gonadotropin-alfa) have not been established for seniors.